FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Eriko Tokunaga

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Procedures

Geographic Areas

Japan

Physiology

Co-author Network

Publications

TOP 3
Nami Yamashita; Shinichi Aishima; Sayuri Akiyoshi; Yuichi Hisamatsu; Hiroyuki Kitao; Masaru Morita; Satoko Okada; Kenji Taketani; Eriko Tokunaga; Yoshihiko Maehara
Vimentin as a poor prognostic factor for triple-negative breast cancer.
Masaru Morita; Eiji Oki; Hajime Otsu; Hiroshi Saeki; Kenji Taketani; Eriko Tokunaga; Koji Ando; Satoshi Ida; Tetsuo Ikeda; Hiroyuki Kawano; Yasue Kimura; Ryuichi Kumashiro; Tetsuya Kusumoto; Yoshihiko Maehara
Advances in esophageal surgery in elderly patients with thoracic esophageal cancer.
Takeshi Kamitani; Yoshio Matsuo; Michinobu Nagao; Kengo Shirahane; Eriko Tokunaga; Hidetake Yabuuchi; Nobuhiro Fujita; Masamitsu Hatakenaka; Mikako Jinnouchi; Hiroshi Honda
Detection of axillary node metastasis using diffusion-weighted MRI in breast cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Eriko Tokunaga (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Nami Yamashita; Shinichi Aishima; Sayuri Akiyoshi; Yuichi Hisamatsu; Hiroyuki Kitao; Masaru Morita; Satoko Okada; Kenji Taketani; Eriko Tokunaga; Yoshihiko Maehara
Vimentin as a poor prognostic factor for triple-negative breast cancer.
Journal of cancer research and clinical oncology 2013;139(5):739-46.
2013: Masaru Morita; Eiji Oki; Hajime Otsu; Hiroshi Saeki; Kenji Taketani; Eriko Tokunaga; Koji Ando; Satoshi Ida; Tetsuo Ikeda; Hiroyuki Kawano; Yasue Kimura; Ryuichi Kumashiro; Tetsuya Kusumoto; Yoshihiko Maehara
Advances in esophageal surgery in elderly patients with thoracic esophageal cancer.
Anticancer research 2013;33(4):1641-7.
2013: Takeshi Kamitani; Yoshio Matsuo; Michinobu Nagao; Kengo Shirahane; Eriko Tokunaga; Hidetake Yabuuchi; Nobuhiro Fujita; Masamitsu Hatakenaka; Mikako Jinnouchi; Hiroshi Honda
Detection of axillary node metastasis using diffusion-weighted MRI in breast cancer.
Clinical imaging 2013;37(1):56-61.
2012: Ryota Nakanishi; Eriko Tokunaga; Natsumi Yamashita; Nami Yamashita; Yoshihiko Fujinaka; Makoto Iimori; Yoshihiro Kakeji; Hiroyuki Kitao; Masaru Morita; Yoshihiko Maehara
FANCJ expression predicts the response to 5-fluorouracil-based chemotherapy in MLH1-proficient colorectal cancer.
Annals of surgical oncology 2012;19(11):3627-35.
2012: Eriko Tokunaga; Yuichi Hisamatsu; Yoshihiko Maehara
[FOXA1 expression in luminal-type breast cancer].
Nihon rinsho. Japanese journal of clinical medicine 2012;70 Suppl 7():438-42.
2012: Satoko Okada; Eiji Oki; Hiroshi Saeki; Eriko Tokunaga; Nami Yamashita; Sayuri Akiyoshi; Yoshihiro Kakeji; Hiroyuki Kitao; Masaru Morita; Yoshihiko Maehara
Loss of heterozygosity at BRCA1 locus is significantly associated with aggressiveness and poor prognosis in breast cancer.
Annals of surgical oncology 2012;19(5):1499-507.
2012: Yuichi Hisamatsu; Yoshihiro Kakeji; Shinichi Aishima; Sayuri Akiyoshi; Masaru Morita; Yuichiro Nakashima; Satoko Okada; Eriko Tokunaga; Nami Yamashita; Yoshihiko Maehara
Impact of FOXA1 expression on the prognosis of patients with hormone receptor-positive breast cancer.
Annals of surgical oncology 2012;19(4):1145-52.
2012: Eriko Tokunaga; Nami Yamashita; Masaru Morita; Satoko Okada; Sayuri Akiyoshi; Yoshihiro Kakeji; Hiroyuki Kitao; Yoshihiko Maehara
High incidence and frequency of LOH are associated with aggressive features of high-grade HER2 and triple-negative breast cancers.
Breast cancer (Tokyo, Japan) 2012;19(2):161-9.
2011: Takeshi Kamitani; Makoto Kubo; Yoshio Matsuo; Takashi Okafuji; Shuji Sakai; Taro Setoguchi; Shunya Sunami; Eriko Tokunaga; Hidetake Yabuuchi; Hidetaka Yamamoto; Masamitsu Hatakenaka; Nobuhide Ishii; Hiroshi Honda
Diagnostic performance in differentiation of breast lesion on digital mammograms: comparison among hard-copy film, 3-megapixel LCD monitor, and 5-megapixel LCD monitor.
Clinical imaging 2011;35(5):341-5.
2011: Eriko Tokunaga; Satoko Okada; Hiroyuki Kitao; Satoko Shiotani; Hiroshi Saeki; Kazuya Endo; Masaru Morita; Yoshihiro Kakeji; Yoshihiko Maehara
Low incidence of methylation of the promoter region of the FANCF gene in Japanese primary breast cancer.
Breast cancer (Tokyo, Japan) 2011;18(2):120-3.
2011: Hidetake Yabuuchi; Yoshio Matsuo; Shunya Sunami; Takeshi Kamitani; Satoshi Kawanami; Taro Setoguchi; Shuji Sakai; Masamitsu Hatakenaka; Makoto Kubo; Eriko Tokunaga; Hidetaka Yamamoto; Hiroshi Honda
Detection of non-palpable breast cancer in asymptomatic women by using unenhanced diffusion-weighted and T2-weighted MR imaging: comparison with mammography and dynamic contrast-enhanced MR imaging.
European radiology 2011;21(1):11-7.
2010: Hirotaka Koga; Eriko Tokunaga; Mami Hidaka; Yuuka Umemura; Tsuguyuki Saito; Akira Isogai; Takuya Kitaoka
Topochemical synthesis and catalysis of metal nanoparticles exposed on crystalline cellulose nanofibers.
Chemical communications (Cambridge, England) 2010;46(45):8567-9.
2010: Hidetake Yabuuchi; Yoshio Matsuo; Takeshi Kamitani; Taro Setoguchi; Takashi Okafuji; Hiroyasu Soeda; Shuji Sakai; Masamitsu Hatakenaka; Makoto Kubo; Eriko Tokunaga; Hidetaka Yamamoto; Hiroshi Honda
Non-mass-like enhancement on contrast-enhanced breast MR imaging: lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images.
European journal of radiology 2010;75(1):e126-32.
2010: Morimasa Tomikawa; Jaesung Hong; Satoko Shiotani; Eriko Tokunaga; Kozo Konishi; Satoshi Ieiri; Kazuo Tanoue; Tomohiko Akahoshi; Yoshihiko Maehara; Makoto Hashizume
Real-time 3-dimensional virtual reality navigation system with open MRI for breast-conserving surgery.
Journal of the American College of Surgeons 2010;210(6):927-33.
2010: Jeong-Hun Kang; Yoji Asami; Masaharu Murata; Hirotaro Kitazaki; Noriaki Sadanaga; Eriko Tokunaga; Satoko Shiotani; Satoko Okada; Yoshihiko Maehara; Takuro Niidome; Makoto Hashizume; Takeshi Mori; Yoshiki Katayama
Gold nanoparticle-based colorimetric assay for cancer diagnosis.
Biosensors & bioelectronics 2010;25(8):1869-74.
2009: Masaru Morita; Takanobu Masuda; Satoko Okada; Keiji Yoshinaga; Hiroshi Saeki; Eriko Tokunaga; Kazuya Endo; Yasunori Emi; Yoshihiro Kakeji; Yoshihiko Maehara
Preoperative chemoradiotherapy for esophageal cancer: factors associated with clinical response and postoperative complications.
Anticancer research 2009;29(7):2555-62.
2009: Eiji Oki; Zhao Yan; Rintaro Yoshida; Takanobu Masuda; Koji Ando; Masahiiko Sugiyama; Eriko Tokunaga; Masaru Morita; Yoshihiro Kakeji; Yoshihiko Maehara
Checkpoint with forkhead-associated and ring finger promoter hypermethylation correlates with microsatellite instability in gastric cancer.
World journal of gastroenterology : WJG 2009;15(20):2520-5.
2008: Hiroyuki Kitao; Yoshihiko Fujinaka; Nobuhide Kubo; Tomonori Nakanoko; Keiji Yoshinaga; Eriko Tokunaga; Hiroshi Saeki; Kazuya Endo; Masaru Morita; Yoshihiro Kakeji; Yoshihiko Maehara
[Fanconi anemia and genomic instability].
Fukuoka igaku zasshi = Hukuoka acta medica 2008;99(6):115-22.
2008: Tadashi Koga; Eriko Tokunaga; Yasushi Sumiyoshi; Eiji Oki; Shinya Oda; Ikuo Takahashi; Yoshihiro Kakeji; Hideo Baba; Yoshihiko Maehara
Detection of circulating gastric cancer cells in peripheral blood using real time quantitative RT-PCR.
Hepato-gastroenterology 2008;55(84):1131-5.
2008: Eriko Tokunaga; Eiji Oki; Akinori Egashira; Noriaki Sadanaga; Masaru Morita; Yoshihiro Kakeji; Yoshihiko Maehara
Deregulation of the Akt pathway in human cancer.
Current cancer drug targets 2008;8(1):27-36.
2008: Takashi Okafuji; Hidetake Yabuuchi; Hiroyasu Soeda; Yoshio Matsuo; Takeshi Kamitani; Shuji Sakai; Masamitsu Hatakenaka; Syoji Kuroki; Eriko Tokunaga; Hidetaka Yamamoto; Hiroshi Honda
Circumscribed mass lesions on mammography: dynamic contrast-enhanced MR imaging to differentiate malignancy and benignancy.
Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine 2008;7(4):195-204.
2007: Eiji Oki; Yoshihiro Kakeji; Hideo Baba; Kojiro Nishida; Tadashi Koga; Eriko Tokunaga; Akinori Egashira; Keisuke Ikeda; Rintaro Yoshida; Manabu Yamamoto; Masaru Morita; Yoshihiko Maehara
Clinical significance of cytokeratin positive cells in bone marrow of gastric cancer patients.
Journal of cancer research and clinical oncology 2007;133(12):995-1000.
2007: Eriko Tokunaga; Eiji Oki; Yasue Kimura; Takeharu Yamanaka; Akinori Egashira; Kojiro Nishida; Tadashi Koga; Masaru Morita; Yoshihiro Kakeji; Yoshihiko Maehara
Coexistence of the loss of heterozygosity at the PTEN locus and HER2 overexpression enhances the Akt activity thus leading to a negative progesterone receptor expression in breast carcinoma.
Breast cancer research and treatment 2007;101(3):249-57.
2007: Eiji Oki; Mitsuhiko Ota; Takuya Honbo; Akinori Egashira; Eriko Tokunaga; Noriaki Sadanaga; Masaru Morita; Yoshihiro Kakeji; Yoshihiko Maehara
[Molecular target therapy for colonic neoplasms].
Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 2007;96(2):289-94.
2006: Hidetake Yabuuchi; Hiroyasu Soeda; Yoshio Matsuo; Takashi Okafuji; Takashi Eguchi; Shuji Sakai; Syoji Kuroki; Eriko Tokunaga; Shinji Ohno; Kenichi Nishiyama; Masamitsu Hatakenaka; Hiroshi Honda
Phyllodes tumor of the breast: correlation between MR findings and histologic grade.
Radiology 2006;241(3):702-9.
2006: Takashi Okafuji; Hidetake Yabuuchi; Shuji Sakai; Hiroyasu Soeda; Yoshio Matsuo; Takahiro Inoue; Masamitsu Hatakenaka; Naoki Takahashi; Syoji Kuroki; Eriko Tokunaga; Hiroshi Honda
MR imaging features of pure mucinous carcinoma of the breast.
European journal of radiology 2006;60(3):405-13.
2006: Eiji Oki; Yoshihiro Kakeji; Rintaro Yoshida; Keisuke Ikeda; Kojiro Nishida; Tadashi Koga; Akinori Egashira; Eriko Tokunaga; Masaru Morita; Hideo Baba; Yoshihiko Maehara
[A randomized controlled trial to evaluate the effect of adjuvant oral fluoropyrimidine derivative therapy after curative resection for stage II/III rectal cancer-adjuvant chemotherapy trial of S-1 for rectal cancer (ACTS-RC):].
Gan to kagaku ryoho. Cancer & chemotherapy 2006;33 Suppl 1():138-43.
2006: Eriko Tokunaga; Eiji Oki; Kojiro Nishida; Tadashi Koga; Akinori Egashira; Masaru Morita; Yoshihiro Kakeji; Yoshihiko Maehara
Trastuzumab and breast cancer: developments and current status.
International journal of clinical oncology 2006;11(3):199-208.
2006: Eiji Oki; Yoshihiro Kakeji; Hideo Baba; Eriko Tokunaga; Toshihiko Nakamura; Naoyuki Ueda; Motonori Futatsugi; Manabu Yamamoto; Masahiko Ikebe; Yoshihiko Maehara
Impact of loss of heterozygosity of encoding phosphate and tensin homolog on the prognosis of gastric cancer.
Journal of gastroenterology and hepatology 2006;21(5):814-8.
2006: Eriko Tokunaga; Eiji Oki; Kojiro Nishida; Tadashi Koga; Rintaro Yoshida; Keisuke Ikeda; Aya Kojima; Akinori Egashira; Masaru Morita; Yoshihiro Kakeji; Yoshihiko Maehara
Aberrant hypermethylation of the promoter region of the CHFR gene is rare in primary breast cancer.
Breast cancer research and treatment 2006;97(2):199-203.
2006: Ikuo Takahashi; Yasunori Emi; Yoshihiro Kakeji; Eriko Tokunaga; Shin Ushiro; Eiji Oki; Masayuki Watanabe; Hideo Baba; Yoshihiko Maehara
Phase I study of S-1 and biweekly docetaxel combination chemotherapy for advanced and recurrent gastric cancer.
Oncology reports 2006;15(4):849-54.
2006: Eriko Tokunaga; Akemi Kataoka; Yasue Kimura; Eiji Oki; Kohjiro Mashino; Kojiro Nishida; Tadashi Koga; Masaru Morita; Yoshihiro Kakeji; Hideo Baba; Shinji Ohno; Yoshihiko Maehara
The association between Akt activation and resistance to hormone therapy in metastatic breast cancer.
European journal of cancer (Oxford, England : 1990) 2006;42(5):629-35.
2006: Yoshihiko Maehara; Eiji Oki; Eriko Tokunaga; Shin-ichiro Maehara; Eiji Tsujita; Yoichi Yamashita; Akinori Egashira; Akinobu Taketomi; Kakeji Yoshihiro
[Development of a molecular target therapy on the basis of global gene analyses of gastrointestinal carcinoma].
Fukuoka igaku zasshi = Hukuoka acta medica 2006;97(2):30-6.
2006: Eriko Tokunaga; Yasue Kimura; Eiji Oki; Naoyuki Ueda; Motonori Futatsugi; Kohjiro Mashino; Manabu Yamamoto; Masahiko Ikebe; Yoshihiro Kakeji; Hideo Baba; Yoshihiko Maehara
Akt is frequently activated in HER2/neu-positive breast cancers and associated with poor prognosis among hormone-treated patients.
International journal of cancer. Journal international du cancer 2006;118(2):284-9.
2006: Eriko Tokunaga; Yasue Kimura; Kohjiro Mashino; Eiji Oki; Akemi Kataoka; Shinji Ohno; Masaru Morita; Yoshihiro Kakeji; Hideo Baba; Yoshihiko Maehara
Activation of PI3K/Akt signaling and hormone resistance in breast cancer.
Breast cancer (Tokyo, Japan) 2006;13(2):137-44.
2005: Eiji Oki; Hideo Baba; Eriko Tokunaga; Toshihiko Nakamura; Naoyuki Ueda; Motonori Futatsugi; Kohjiro Mashino; Manabu Yamamoto; Masahiko Ikebe; Yoshihiro Kakeji; Yoshihiko Maehara
Akt phosphorylation associates with LOH of PTEN and leads to chemoresistance for gastric cancer.
International journal of cancer. Journal international du cancer 2005;117(3):376-80.
2005: Eiji Oki; Eriko Tokunaga; Toshihiko Nakamura; Naoyuki Ueda; Motonori Futatsugi; Kohjiro Mashino; Manabu Yamamoto; Masayuki Watanabe; Masahiko Ikebe; Yoshihiro Kakeji; Hideo Baba; Yoshihiko Maehara
Genetic mutual relationship between PTEN and p53 in gastric cancer.
Cancer letters 2005;227(1):33-8.
2004: Eriko Tokunaga; Yasue Kimura; Kaoru Kitamura; Yoshihiko Maehara
Granulomatous lobular mastitis misdiagnosed as breast carcinoma.
The breast journal 2004;10(3):261-2.
2004: Eriko Tokunaga; Yasue Kimura; Yoshihiko Maehara
No hypersensitive estrogen receptor-alpha mutation (K303R) in Japanese breast carcinomas.
Breast cancer research and treatment 2004;84(3):289-92.
2003: Hideo Baba; Yoshihiro Kakeji; Eiji Oki; Eriko Tokunaga; Shin Ushiro; Masayuki Watanabe; Yoshihiko Maehara
[Chemotherapy for gastric cancer].
Gan to kagaku ryoho. Cancer & chemotherapy 2003;30(12):1881-8.
2003: Yoshihiko Maehara; Yoshihiro Kakeji; Takaaki Masuda; Taro Sakoguchi; Msakazu Imamura; Kippei Ohgaki; Koji Taniguchi; Masato Sakurai; Motonori Futatsugi; Yasue Kimura; Toshihiko Nakamura; Eriko Tokunaga; Eiji Oki; Shin Ushiro; Masayuki Watanabe; Shinya Oda; Shuji Tanaka; Hideo Baba
[Treatment of gastric cancer: current state and future prospect].
Fukuoka igaku zasshi = Hukuoka acta medica 2003;94(10):285-95.
2003: Hideya Takeuchi; Yoshihiko Maehara; Eriko Tokunaga; Takashi Koga; Yoshihiko Kakeji; Keizo Sugimachi
Prognostic value of preoperative immunosuppressive acidic protein levels in patients with gastric carcinoma.
Hepato-gastroenterology 2003;50(49):289-92.
2002: Eiji Oki; Yoshihiko Maehara; Eriko Tokunaga; Kotaro Shibahara; Shota Hasuda; Yoshihiro Kakeji; Keizo Sugimachi
Detection of disseminated cancer cells in bone marrow of gastric cancer using real time quantitative reverse transcriptase polymerase chain reaction.
Cancer letters 2002;188(1-2):191-8.
2002: Yoshihiko Maehara; Yasunori Emi; Shinji Tanaka; Eriko Tokunaga; Hideya Takeuchi; Ikuo Takahashi; Yoshihisa Sakaguchi; Tetsuya Kusumoto; Sunshi Fujiya; Hironori Kusumoto; Hideaki Anai; Yuji Nagayoshi; Toshiharu Konoe; Hidetaka Masuda
[Departmental review of surgical cases in the last 17 years: The Cancer Research Center].
Fukuoka igaku zasshi = Hukuoka acta medica 2002;93(3 Suppl):42-6.
2001: Hiroshi Saeki; Shinji Tanaka; Eriko Tokunaga; Hidetoshi Kawaguchi; Yoichi Ikeda; Yoshihiko Maehara; Keishi Sugimachi
Genetic alterations in the human Tcf-4 gene in Japanese patients with sporadic gastrointestinal cancers with microsatellite instability.
Oncology 2001;61(2):156-61.
2001: Yoshihiro Kakeji; Yoshihiko Maehara; Tadashi Koga; Kotaro Shibahara; Akira Kabashima; Eriko Tokunaga; Keishi Sugimachi
Gastric cancer with high telomerase activity shows rapid development and invasiveness.
Oncology reports 2001;8(1):107-10.
2000: Eriko Tokunaga; S Oda; M Fukushima; Y Maehara; K Sugimachi
Differential growth inhibition by 5-fluorouracil in human colorectal carcinoma cell lines.
European journal of cancer (Oxford, England : 1990) 2000;36(15):1998-2006.
2000: Eriko Tokunaga; Y Maehara; Eiji Oki; T Koga; Y Kakeji; K Sugimachi
Application of quantitative RT-PCR using "TaqMan" technology to evaluate the expression of CK 18 mRNA in various cell lines.
Journal of experimental & clinical cancer research : CR 2000;19(3):375-81.
2000: Yoshihiko Maehara; Akira Kabashima; Tadashi Koga; Eriko Tokunaga; H Takeuchi; Yoshihiro Kakeji; Keishi Sugimachi
Vascular invasion and potential for tumor angiogenesis and metastasis in gastric carcinoma.
Surgery 2000;128(3):408-16.
2000: Eriko Tokunaga; Eiji Oki; S Oda; A Kataoka; K Kitamura; S Ohno; Y Maehara; K Sugimachi
Frequency of microsatellite instability inBreast cancer determined by high-resolution fluorescent microsatellite analysis.
Oncology 2000;59(1):44-9.
2000: Eriko Tokunaga; Y Maehara; Eiji Oki; K Kitamura; Y Kakeji; S Ohno; K Sugimachi
Diminished expression of ING1 mRNA and the correlation with p53 expression in breast cancers.
Cancer letters 2000;152(1):15-22.
2000: Yoshihiko Maehara; Shota Hasuda; T Koga; Eriko Tokunaga; Yoshihiro Kakeji; Keishi Sugimachi
Postoperative outcome and sites of recurrence in patients following curative resection of gastric cancer.
The British journal of surgery 2000;87(3):353-7.
2000: Yoshihiko Maehara; Eiji Oki; T Abe; Eriko Tokunaga; Kotaro Shibahara; Yoshihiro Kakeji; Keishi Sugimachi
Overexpression of the heat shock protein HSP70 family and p53 protein and prognosis for patients with gastric cancer.
Oncology 2000;58(2):144-51.
1999: Eiji Oki; Y Maehara; Eriko Tokunaga; Y Kakeji; K Sugimachi
Reduced expression of p33(ING1) and the relationship with p53 expression in human gastric cancer.
Cancer letters 1999;147(1-2):157-62.
1999: Yoshihiko Maehara; M Tomoda; Shota Hasuda; Akira Kabashima; Eriko Tokunaga; Yoshihiro Kakeji; Keishi Sugimachi
Prognostic value of p53 protein expression for patients with gastric cancer--a multivariate analysis.
British journal of cancer 1999;79(7-8):1255-61.
1999: Yoshihiko Maehara; Akira Kabashima; Eriko Tokunaga; Shota Hasuda; Eiji Oki; Yoshihiro Kakeji; Hideo Baba; Keishi Sugimachi
Recurrences and relation to tumor growth potential and local immune response in node-negative advanced gastric cancer.
Oncology 1999;56(4):322-7.
1998: Eiji Oki; S Oda; Eriko Tokunaga; Y Maehara; K Sugimachi
[A new microsatellite instability analysis using fluorescent primers and laser scanning].
Gan to kagaku ryoho. Cancer & chemotherapy 1998;25 Suppl 3():436-42.
1997: Y Toh; Eiji Oki; Shinya Oda; Eriko Tokunaga; Shinji Ohno; Yoshihiko Maehara; G L Nicolson; Keishi Sugimachi
Overexpression of the MTA1 gene in gastrointestinal carcinomas: correlation with invasion and metastasis.
International journal of cancer. Journal international du cancer 1997;74(4):459-63.